Preventing infectious diseases with proven adjuvant technology

Committed to developing
novel vaccines

We are a commercial-stage biopharmaceutical company committed to developing and commercializing novel vaccines to help protect the world against infectious diseases, by utilizing proven, innovative adjuvant technology.

who we are

Make A Difference

Join a dynamic team dedicated to making a difference

Our mission and passion for what we do are guided by the collective ideals underpinning Our Values, and these form the basis of our company culture.

Join Us


DYNAVAX®, HEPLISAV-B®, and CpG 1018® are registered trademarks of Dynavax Technologies Corporation.